Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

59.6K
Overview
59.6K
What are Viruses?00:50

What are Viruses?

127.9K
Overview
127.9K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

14.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
What is Natural Selection?01:32

What is Natural Selection?

126.5K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
126.5K
Types of Selection01:46

Types of Selection

44.2K
Natural selection influences the frequencies of particular alleles and phenotypes within populations in several different ways. Primarily, natural selection can be directional, stabilizing, or disruptive. Directional selection favors one extreme trait and shifts the population towards that phenotype while selecting against individuals displaying alternate traits. Stabilizing selection favors an intermediate trait with a narrow range of variation. Deviation from the optimal phenotype towards an...
44.2K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A refined coadministration regime to mitigate immunological clearance of biomedical nanoparticles.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same author

Coumarin-Caged Nanoparticle for Light-Driven Surface Modification.

ChemMedChem·2025
Same author

Interprofessional Therapeutic Drug Monitoring of Piperacillin/Tazobactam Enhances Care for Patients with Acute-on-Chronic Liver Failure in the ICU: A Retrospective Observational Pilot Study.

Antibiotics (Basel, Switzerland)·2025
Same author

The quantity of ligand-receptor interactions between nanoparticles and target cells.

Nanoscale horizons·2025
Same author

Interprofessional approach to personalized medication management and therapy optimization in IBD care.

Frontiers in medicine·2025
Same author

Solid-state fermentation of hemp waste: enhancing the performance of <i>Hermetia illucens</i> larvae and altering the composition of hemp secondary metabolites.

Frontiers in bioengineering and biotechnology·2025

Related Experiment Video

Updated: Jan 25, 2026

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
12:09

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells

Published on: November 22, 2017

18.8K

Influenza A virus mimetic nanoparticles trigger selective cell uptake.

Sara Maslanka Figueroa1, Anika Veser1, Kathrin Abstiens1

  • 1Department of Pharmaceutical Technology, University of Regensburg, 93053 Regensburg, Germany.

Proceedings of the National Academy of Sciences of the United States of America
|May 1, 2019
PubMed
Summary

Researchers developed virus-mimetic nanoparticles that precisely target specific cells. These nanoparticles overcome poor specificity in biomedical applications, improving drug delivery and diagnostics for diseases like diabetic nephropathy.

Keywords:
enzyme responsiveheteromultivalentinfluenza Atarget specificvirus-mimetic nanoparticles

More Related Videos

Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry
07:25

Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry

Published on: November 4, 2015

10.6K
Imaging Denatured Collagen Strands In vivo and Ex vivo via Photo-triggered Hybridization of Caged Collagen Mimetic Peptides
07:03

Imaging Denatured Collagen Strands In vivo and Ex vivo via Photo-triggered Hybridization of Caged Collagen Mimetic Peptides

Published on: January 31, 2014

12.3K

Related Experiment Videos

Last Updated: Jan 25, 2026

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells
12:09

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells

Published on: November 22, 2017

18.8K
Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry
07:25

Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry

Published on: November 4, 2015

10.6K
Imaging Denatured Collagen Strands In vivo and Ex vivo via Photo-triggered Hybridization of Caged Collagen Mimetic Peptides
07:03

Imaging Denatured Collagen Strands In vivo and Ex vivo via Photo-triggered Hybridization of Caged Collagen Mimetic Peptides

Published on: January 31, 2014

12.3K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cell Biology

Background:

  • Nanoparticles (NPs) often lack target cell specificity, leading to material loss and reduced efficacy.
  • Current NP delivery methods struggle with precise targeting in complex biological environments.

Purpose of the Study:

  • To design virus-mimetic nanoparticles with enhanced target cell specificity for biomedical applications.
  • To overcome the limitations of off-target delivery and improve NP availability at intended sites.

Main Methods:

  • Developed NPs mimicking influenza A virus activation mechanism.
  • Utilized a two-stage targeting approach: Angiotensin I (Ang-I) proligand for angiotensin-converting enzyme (ACE) on mesangial cells, followed by Angiotensin II (Ang-II) binding to Ang-II type-1 receptor (AT1R).
  • Assessed NP selectivity in a mixed cell population containing target and off-target cells.

Main Results:

  • Achieved high target-cell affinity with picomolar avidities.
  • Demonstrated selective identification of mesangial cells in the presence of 90% off-target cells.
  • Virus-mimetic NPs successfully triggered uptake via endocytosis upon confirming target cell identity.

Conclusions:

  • Virus-mimetic NP design is a valuable strategy for enhancing specificity in therapeutic and diagnostic applications.
  • The developed NPs are particularly suited for targeting mesangial cells, relevant to diabetic nephropathy.
  • This approach offers a potential new avenue for treating diseases with no current effective treatments.